MMP9 and fragile X syndrome: Minocycline, which inhibits excessive activity of MMP9, normalizing some synaptic and behavioral phenotypes in the Fmr-1 knockout mouse model [38], also had positive effects on behavioral symptoms such as irritability, hyperactivity, and stereotypy in FXS in a small open-label trial [14].